# IVI Aflibercept Before and After Phaco in DME.

> **NCT05731089** · NA · COMPLETED · sponsor: **Al Hadi Hospital** · enrollment: 40 (actual)

## Conditions studied

- Diabetic Macular Edema

## Interventions

- **PROCEDURE:** Phacoemulsification with IVI of aflibercept

## Key facts

- **NCT ID:** NCT05731089
- **Lead sponsor:** Al Hadi Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-01
- **Primary completion:** 2022-08-01
- **Final completion:** 2022-12-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2023-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05731089

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05731089, "IVI Aflibercept Before and After Phaco in DME.". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT05731089. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*